WI
CNMD icon

Wafra Inc’s CONMED CNMD Stock Holding History

Wafra Inc’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-44,259
Closed -$3.55M – 68
2022
Q3 		$3.55M Hold
44,259
– – 0.14% 66
2022
Q2 		$4.24M Sell
44,259
-94,283
-68% -$11.3M 0.16% 65
2022
Q1 		$20.6M Hold
138,542
– – 0.71% 44
2021
Q4 		$19.6M Hold
138,542
– – 0.62% 51
2021
Q3 		$18.1M Hold
138,542
– – 0.66% 46
2021
Q2 		$19M Buy
138,542
+25,581
+23% +$3.5M 0.72% 47
2021
Q1 		$14.8M Buy
+112,961
New +$13.6M 0.61% 49

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Wafra Inc's CNMD Position: Q4 2022 in Review

Wafra Inc sold out of CONMED (CNMD) in Q4 2022, closing a stake of 44,259 shares — an estimated $3.55M sold.

Wafra Inc first reported a position in CNMD in Q1 2021 and held it in 7 quarters. The position peaked at $20.6M in Q1 2022. 238 funds tracked by Wall St. Rank hold CNMD as of Q4 2022.

  • Wafra Inc reported no remaining CONMED position as of Q4 2022 after selling out during the quarter.
  • Wafra Inc sold 44,259 CONMED shares in Q4 2022, an estimated $3.55M.
  • Wafra Inc first reported a position in CONMED in Q1 2021 and held it in 7 quarters.
  • Wafra Inc's CONMED position peaked at $20.6M in Q1 2022.
  • 238 funds tracked by Wall St. Rank held CONMED as of Q4 2022.

Based on Wafra Inc's 13F filing for Q4 2022, filed 31 Jan 2023.